137 related articles for article (PubMed ID: 33684886)
1. Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study.
Mao D; Cao H; Shi M; Wang CC; Kwong J; Li JJX; Hou Y; Ming X; Lee HM; Tian XY; Wong CK; Chow E; Kong APS; Lui VWY; Chan PKS; Chan JCN
EBioMedicine; 2021 Mar; 65():103242. PubMed ID: 33684886
[TBL] [Abstract][Full Text] [Related]
2. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
3. Exendin-4 improves behaviorial deficits via GLP-1/GLP-1R signaling following partial hepatectomy.
Zhou Y; Li Z; Cao X; Ma H; White PF; Xu X; Jiang Y; Sun X; Cui Y
Brain Res; 2019 Mar; 1706():116-124. PubMed ID: 30408479
[TBL] [Abstract][Full Text] [Related]
4. GLP-1R activation ameliorated novel-object recognition memory dysfunction via regulating hippocampal AMPK/NF-κB pathway in neuropathic pain mice.
Zhang LQ; Zhang W; Li T; Yang T; Yuan X; Zhou Y; Zou Q; Yang H; Gao F; Tian Y; Mei W; Tian XB
Neurobiol Learn Mem; 2021 Jul; 182():107463. PubMed ID: 34015440
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1.
Marzook A; Chen S; Pickford P; Lucey M; Wang Y; Corrêa IR; Broichhagen J; Hodson DJ; Salem V; Rutter GA; Tan TM; Bloom SR; Tomas A; Jones B
Biochem Pharmacol; 2021 Aug; 190():114656. PubMed ID: 34129856
[TBL] [Abstract][Full Text] [Related]
6. Activation of overexpressed glucagon-like peptide-1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression.
Shigeoka T; Nomiyama T; Kawanami T; Hamaguchi Y; Horikawa T; Tanaka T; Irie S; Motonaga R; Hamanoue N; Tanabe M; Nabeshima K; Tanaka M; Yanase T; Kawanami D
J Diabetes Investig; 2020 Sep; 11(5):1137-1149. PubMed ID: 32146725
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory switch from Gαs to Gαi signaling by Glucagon-like peptide-1 receptor in murine splenic monocyte following burn injury.
Zhang QH; Hao JW; Li GL; Ji XJ; Yao XD; Dong N; Yao YM
Inflamm Res; 2018 Feb; 67(2):157-168. PubMed ID: 29022064
[TBL] [Abstract][Full Text] [Related]
8. Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-κB Activation.
Iwaya C; Nomiyama T; Komatsu S; Kawanami T; Tsutsumi Y; Hamaguchi Y; Horikawa T; Yoshinaga Y; Yamashita S; Tanaka T; Terawaki Y; Tanabe M; Nabeshima K; Iwasaki A; Yanase T
Endocrinology; 2017 Dec; 158(12):4218-4232. PubMed ID: 29045658
[TBL] [Abstract][Full Text] [Related]
9. Normalisation of glucose metabolism by exendin-4 in the chronic phase after stroke promotes functional recovery in male diabetic mice.
Augestad IL; Dekens D; Karampatsi D; Elabi O; Zabala A; Pintana H; Larsson M; Nyström T; Paul G; Darsalia V; Patrone C
Br J Pharmacol; 2022 Feb; 179(4):677-694. PubMed ID: 33973246
[TBL] [Abstract][Full Text] [Related]
10. Exendin-4 inhibits glioma cell migration, invasion and epithelial-to-mesenchymal transition through GLP-1R/sirt3 pathway.
Nie ZJ; Zhang YG; Chang YH; Li QY; Zhang YL
Biomed Pharmacother; 2018 Oct; 106():1364-1369. PubMed ID: 30119208
[TBL] [Abstract][Full Text] [Related]
11. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
12. Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking.
Lucey M; Ashik T; Marzook A; Wang Y; Goulding J; Oishi A; Broichhagen J; Hodson DJ; Minnion J; Elani Y; Jockers R; Briddon SJ; Bloom SR; Tomas A; Jones B
Mol Pharmacol; 2021 Oct; 100(4):319-334. PubMed ID: 34315812
[TBL] [Abstract][Full Text] [Related]
13. Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4.
Lietzau G; Nyström T; Östenson CG; Darsalia V; Patrone C
Oncotarget; 2016 Feb; 7(5):5865-76. PubMed ID: 26744321
[TBL] [Abstract][Full Text] [Related]
14. Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner.
Wei R; Ma S; Wang C; Ke J; Yang J; Li W; Liu Y; Hou W; Feng X; Wang G; Hong T
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E947-57. PubMed ID: 27072494
[TBL] [Abstract][Full Text] [Related]
15. GLP-1 receptor agonists stimulate ANGPTL8 production through the PI3K/Akt pathway in a GLP-1 receptor-dependent manner.
Liu J; Yang K; Xiao W; Le Y; Lang S; Zhang J; Wei R; Yang J; Hong T
Peptides; 2018 Aug; 106():83-90. PubMed ID: 30003931
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
Li Y; Tweedie D; Mattson MP; Holloway HW; Greig NH
J Neurochem; 2010 Jun; 113(6):1621-31. PubMed ID: 20374430
[TBL] [Abstract][Full Text] [Related]
17. Indirectly radioiodinated exendin-4 as an analytical tool for in vivo detection of glucagon-like peptide-1 receptor in a disease setting.
Kondo N; Oishi A; Hirata M; Temma T
Ann Nucl Med; 2021 Jan; 35(1):83-91. PubMed ID: 33067731
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4 Derivatives with an Albumin-Binding Moiety Show Decreased Renal Retention and Improved GLP-1 Receptor Targeting.
Kaeppeli SAM; Jodal A; Gotthardt M; Schibli R; Béhé M
Mol Pharm; 2019 Sep; 16(9):3760-3769. PubMed ID: 31393738
[TBL] [Abstract][Full Text] [Related]
19. Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats.
Candeias E; Sebastião I; Cardoso S; Carvalho C; Santos MS; Oliveira CR; Moreira PI; Duarte AI
Mol Neurobiol; 2018 May; 55(5):4030-4050. PubMed ID: 28573460
[TBL] [Abstract][Full Text] [Related]
20. Exendin-4 enhances proliferation of senescent osteoblasts through activation of the IGF-1/IGF-1R signaling pathway.
Zhang M; Xie Y; Zhou Y; Chen X; Xin Z; An J; Hou J; Chen Z
Biochem Biophys Res Commun; 2019 Aug; 516(1):300-306. PubMed ID: 31256933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]